Skip to content

Salt and Hypertension: Is arterial function affected by dietary salt intake?

The impact of dietary salt (NaCl) intake on arterial wall function in hypertensive subjects: a randomised placebo controlled study.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000161224
Enrollment
35
Registered
2009-03-31
Start date
2007-01-24
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Epidemiological studies have demonstrated the association between dietary NaCl intake and hypertension and the risk of cardiovascular disease. Reduction in dietary NaCl intake lowers blood pressure significantly, with a subsequent reduction in cardiovascular events. Reducing dietary NaCl increases arterial compliance and reduces arterial stiffness in older people with systolic hypertension. Experimentally, NaCl affects arterial stiffness by altering vascular structure along with smooth muscle cell and endothelial cell function through a variety of mechanisms. There are only a limited number of studies which have examined the effects of dietary NaCl on arterial wall function in vivo in humans. These studies have focused predominantly on large artery compliance. This study proposes to examine the impact of low, normal and high dietary NaCl on arterial function in normal healthy volunteers. Arterial function can be measured non-invasively by pulse wave analysis, pulse wave velocity and markers of endothelial function. Using these different techniques collectively, we will be able to document the impact of dietary NaCl on arterial compliance in mildly hypertensive individuals. This will then allow for subsequent studies investigating the impact of dietary NaCl in greater at risk populations of hypertensive individuals and those with chronic kidney disease.

Interventions

Dietary salt restriction followed by dietary salt loading. 2 week dietary salt restriction (sodium 60mmol/day) then randomised sequencial allocation to 4 weeks intervention A (tomato juice no added salt 500ml/day), intervention B (tomato juice plus 90mmol sodium, 500ml/day) intervention C (tomato juice plus 140 mmol sodium 500ml/day). There is a 4 week wash out phase between each intervention (no tomato juice). All participants remaining on the low salt diet for the duration of the study. Dieta

Dietary salt restriction followed by dietary salt loading. 2 week dietary salt restriction (sodium 60mmol/day) then randomised sequencial allocation to 4 weeks intervention A (tomato juice no added salt 500ml/day), intervention B (tomato juice plus 90mmol sodium, 500ml/day) intervention C (tomato juice plus 140 mmol sodium 500ml/day). There is a 4 week wash out phase between each intervention (no tomato juice). All participants remaining on the low salt diet for the duration of the study. Dietary compliance was facilitated by weekly dietitic input with advice about low salt foods, fortnightly 4 day diet records. Compliance was measured by urinary sodium/creatinine ratios at baseline, week 1, week 2 and week 4.

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Indviduals with prehypertension or hypertension defined as a systolic blood pressure (SBP) > 130 and/or diastolic blood pressure (DBP) >85 mmHg or on antihypertensive medications

Exclusion criteria

Smokers, any underlying cardiovascular disease, diabetes, renal impairment

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 1, 2026